Diabetes Care:
Diabetes Symptoms, Treatment of Diabetes and Articles on Diabetes Care
-
Nov 5th, 2009
The FDA has received 78 reports of kidney problems related to Byetta, a drug prescribed to treat type 2 diabetes. With the new findings, the drug’s label will be updated to warn doctors and patients about this possible side effect.
-
Nov 3rd, 2009
How much do you know about diabetes? Many Americans do not, according to a recent survey. That is one reason why the American Diabetes Association (ADA) has launched its “Stop Diabetes” campaign as part of American Diabetes Month.
-
Oct 28th, 2009
Vitamin D provides many health benefits, and a new study from New Zealand has added another one to the list. Researchers found that supplements of the vitamin may improve insulin resistance and sensitivity, which are risk factors for diabetes.
-
Oct 25th, 2009
Results of a new study show that old diabetics can improve elasticity of the arteries with aerobic exercise. For the study, researchers were able to show that older diabetics were able to improve artery health in just three months from aerobic exercise.
-
Oct 25th, 2009
According to the American Diabetes Association, 21 million people in the U.S. have diabetes, with about 90 to 95% having type 2 diabetes. New studies are finding that people with type 2 diabetics reverse their condition by lifestyle changes.
-
Oct 21st, 2009
A news release from the International Diabetes Federation (IDF) shows that 285 million people worldwide have diabetes, affecting seven percent of the world’s population. Fifteen years ago, 150 million people were estimated to have diabetes. Diabetes has spread across the globe, reaching epidemic status, posing a threat to health and prosperity.
-
Oct 16th, 2009
New research shows that rats fed high fat diets experienced lower insulin levels when scientists injected resveratrol from grapes directly into their brains. The findings suggest that resveratrol could be developed to target specific brain proteins, in turn offering some protection against diabetes in humans.
-
Oct 2nd, 2009
Dapagliflozin, a new drug for treatment of type 2 diabetes, met its goals in Phase III clinical trials, according to a release issued by the pharmaceutical company AstraZeneca. The investigational drug is a joint venture of AstraZeneca and Bristol-Myers Squibb Company, who plan to file for approval of dapagliflozin with the Food and Drug Administration (FDA) in late 2010 or early 2011.
-
Oct 1st, 2009
Until now, clinicians had no clear evidence that treating mild gestational diabetes could reduce common birth complications among infants and benefit mothers as well. The study was supported by the National Institutes of Health and the National Institute of Child Health and Human Development.
-
Sep 30th, 2009
Heart conditions, such as arrhythmia, and diabetes share common risk factors, including obesity and hypertension, but Type 2 diabetes may independently increase a woman’s risk of atrial fibrillation by as much as 26%, according to new research from the Kaiser Permanente Center for Health Research in Portland, Oregon.